Premier Alternatives

Tasca Therapeutics

Cambridge, MA · Founded 2022 · Privately Held (backing)

Operator of a biotechnology company intended to develop small molecule drugs for hard-to-treat oncology indications. Tasca Therapeutics is based in Cambridge, MA and was founded in 2022. It was valued at $83.3 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $67 million across 1 recorded round; the latest was a $48.1 million early-stage round in Nov 2024.

PMV mark · valuation
$83.3M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$67.0M
Last round
Early Stage VC
Nov 2024

Tasca Therapeutics key facts

as of Oct 2026
  • Operator of a biotechnology company intended to develop small molecule drugs for hard-to-treat oncology indications.
  • Tasca Therapeutics is valued at approximately $83.3M as of Oct 2026, set at its early-stage round, Sep 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $67.0M across 1 recorded rounds; the latest was Early Stage VC ($48.1M) in Nov 2024.
  • Notable investors include 8VC, The Invus Group, TIFF Investment Management, AB Magnitude Ventures Group, Cure Ventures — 7 tracked in total.
  • Tasca Therapeutics has filed 1 Form D with the SEC, most recently Nov 2024 ($24.1M sold to 7 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$83.3M

Valued at $83.3M at its early-stage round, Sep 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Tasca Therapeutics with a free account
  • ·Watch Tasca Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Tasca Therapeutics funding rounds

1 rounds
Nov 2024Early Stage VC$48.1MSEC filing▮
Full funding history →

Tasca Therapeutics valuation

Tasca Therapeutics was valued at $83.3 million at its early-stage round in Sep 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Tasca Therapeutics raised?

Tasca Therapeutics has raised $67 million in total; 1 of its rounds is on record. The largest on record was a $48.1 million early-stage round in Nov 2024.

Tasca Therapeutics has filed 1 Form D with the SEC, most recently in Nov 2024 ($24.1 million sold to 7 investors).

Tasca Therapeutics investors

7 investors are on record for Tasca Therapeutics, including 8VC, The Invus Group, TIFF Investment Management and AB Magnitude Ventures Group. The early-stage round in Nov 2024 drew 9 investors.

About Tasca Therapeutics

Operator of a biotechnology company intended to develop small molecule drugs for hard-to-treat oncology indications. The company develops a pipeline of molecule therapeutics across multiple oncology indications, post-translational modification, and metabolic synergy to expand and effectively target the druggable proteome, enabling doctors to have molecule drugs for hard-to-treat oncology indications.

Sector
Healthcare
HQ
Cambridge, MA, United States
Founded
2022
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.